Medical news and careers, clearly connected
CareZelo
English
Menu

Public health updates

AlertPublic healthCanada

Ebola outbreak reaches 9800 cases as regional travel restrictions tighten

The Ebola outbreak in the Democratic Republic of Congo has passed 9,800 cases and 4,700 deaths since May, the deadliest in the country's history. A nurse was killed and a health worker severely injured on Saturday in Bafwasende while responding to an Ebola alert. A Ugandan-born Swiss woman, Nigeria's first case, was flown from Abuja to Switzerland on Monday; she is stable in Geneva, her husband is in isolation in Zurich, and Nigeria now has no cases. Kenya has nine cases, two fatal; Uganda now requires citizens returning from the DRC to quarantine 21 days at their own expense.

The deadliest Ebola outbreak in DRC history is now spreading across borders — frontline workers should know the travel and quarantine rules as cases reach Nigeria, Kenya and Uganda.

Ask about this brief

Answers are written by AI from this brief and can be wrong. Check the original source before you act.

2 free questions a day without an account. Members ask as often as they like, free.

Not medical, legal or immigration advice. Questions are kept anonymously to improve our briefs.

Read the original

News source: Ebola outbreak reaches 9800 cases as regional travel restrictions tighten (opens in a new tab) — CBC News

Report a problem

Due in 19 daysPublic healthCanada

Accel Pharma reports upcoming two-week shortage of ondansetron 8 mg tablets

Accel Pharma reports its ondansetron orally-disintegrating tablet 8 mg (ACCEL-ONDANSETRON ODT, DIN 02535327) faces an anticipated shortage from Nov 1 to Nov 15, 2026, caused by a shortage of an active ingredient.

Ondansetron is a widely used anti-nausea drug — pharmacies should check stock and alternatives before the anticipated shortage starts Nov 1.

Official source: Health Product Shortages Canada (opens in a new tab)

Due in 19 daysPublic healthCanada

Accel Pharma reports upcoming two-week shortage of ondansetron 4 mg tablets

Accel Pharma reports its ondansetron orally-disintegrating tablet 4 mg (ACCEL-ONDANSETRON ODT, DIN 02535319) faces an anticipated shortage from Nov 1 to Nov 15, 2026, caused by a shortage of an active ingredient.

Ondansetron is a widely used anti-nausea drug — pharmacies should check stock and alternatives before the anticipated shortage starts Nov 1.

Official source: Health Product Shortages Canada (opens in a new tab)

Due in 38 daysPublic healthCanada

Sandoz rabeprazole 20 mg supply disruption expected until early December

Sandoz Canada reports its rabeprazole sodium 20 mg enteric-coated tablet (DIN 02314185) faces an anticipated shortage from Oct 26 to Dec 4, 2026, after a disruption in the manufacture of the drug.

Rabeprazole is a commonly prescribed stomach-acid drug — prescribers and pharmacies should plan alternatives while the shortage is expected.

Official source: Health Product Shortages Canada (opens in a new tab)

Due in 17 daysPublic healthCanada

Sandoz dexamethasone injection supply faces temporary shortage through mid-November

Sandoz Canada reports its dexamethasone sodium phosphate injection 10 mg/mL (DIN 00874582), for intravenous, intramuscular or intrasynovial use, faces an anticipated shortage from Oct 26 to Nov 13, 2026, driven by increased demand.

Dexamethasone injection is a staple steroid in hospitals and clinics — care teams should check stock before the anticipated shortage bites.

Official source: Health Product Shortages Canada (opens in a new tab)